Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (141-150 of 287) with videos related to

Pageof 29
Sort By:
Journal of Crohn'S & Colitis|January 8, 2016
Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative ColitisIris Detrez, Erwin Dreesen, Thomas Van Stappen, et al.
European Journal of Gastroenterology & Hepatology|September 8, 2016
Incidence of renal cell carcinoma in inflammatory bowel disease patients with and without anti-TNF treatmentLucas Wauters, Thomas Billiet, Konstantinos Papamichael, et al.
Inflammatory Bowel Diseases|August 27, 2015
Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor TherapyZhe Li, Séverine Vermeire, Dominique Bullens, et al.
United European Gastroenterology Journal|August 8, 2018
Prognostic value of histological activity in patients with ulcerative colitis in deep remission: A prospective multicenter studyTriana Lobatón, Talat Bessissow, Alexandra Ruiz-Cerulla, et al.
The American Journal of Gastroenterology|February 20, 2003
A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitisGert Van Assche, Ignace Dalle, Maja Noman, et al.
Journal of Autoimmunity|July 30, 2005
Effects of interleukin 4 on CD25+CD4+ regulatory T cell functionPhilippe Maerten, Chong Shen, Dominique M A Bullens, et al.
Journal of Crohn'S & Colitis|November 1, 2015
Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel DiseaseSeverine Vermeire, Marie Joossens, Kristin Verbeke, et al.
Gastroenterology|October 1, 2003
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitisGert Van Assche, Geert D'Haens, Maja Noman, et al.
Journal of Crohn'S & Colitis|May 1, 2015
Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease RecurrenceMarc Ferrante, Konstantinos Papamichael, Dana Duricova, et al.
Scandinavian Journal of Gastroenterology|June 17, 2017
Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn's diseaseThomas Billiet, Isabelle Cleynen, Vera Ballet, et al.
Pageof 29

Showing results (141-150 of 287) with videos related to

Sort By:
Pageof 29
Journal of Crohn'S & Colitis|January 8, 2016
Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative ColitisIris Detrez, Erwin Dreesen, Thomas Van Stappen, et al.
European Journal of Gastroenterology & Hepatology|September 8, 2016
Incidence of renal cell carcinoma in inflammatory bowel disease patients with and without anti-TNF treatmentLucas Wauters, Thomas Billiet, Konstantinos Papamichael, et al.
Inflammatory Bowel Diseases|August 27, 2015
Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor TherapyZhe Li, Séverine Vermeire, Dominique Bullens, et al.
United European Gastroenterology Journal|August 8, 2018
Prognostic value of histological activity in patients with ulcerative colitis in deep remission: A prospective multicenter studyTriana Lobatón, Talat Bessissow, Alexandra Ruiz-Cerulla, et al.
The American Journal of Gastroenterology|February 20, 2003
A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitisGert Van Assche, Ignace Dalle, Maja Noman, et al.
Journal of Autoimmunity|July 30, 2005
Effects of interleukin 4 on CD25+CD4+ regulatory T cell functionPhilippe Maerten, Chong Shen, Dominique M A Bullens, et al.
Journal of Crohn'S & Colitis|November 1, 2015
Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel DiseaseSeverine Vermeire, Marie Joossens, Kristin Verbeke, et al.
Gastroenterology|October 1, 2003
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitisGert Van Assche, Geert D'Haens, Maja Noman, et al.
Journal of Crohn'S & Colitis|May 1, 2015
Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease RecurrenceMarc Ferrante, Konstantinos Papamichael, Dana Duricova, et al.
Scandinavian Journal of Gastroenterology|June 17, 2017
Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn's diseaseThomas Billiet, Isabelle Cleynen, Vera Ballet, et al.
Pageof 29